Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

Overview of attention for article published in Neurology, September 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

f1000: 1 research highlight platform

Citations

dimensions_citation: 200 Dimensions

Readers on

mendeley: 154 Mendeley

Summary X Research highlights Dimensions citations

So far, Dimensions has found 200 publications that cite this research output.

200

The most recent citing publications are shown below. View all 200 publications that cite this research output on Dimensions.

Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review

Article in Experimental Hematology & Oncology (April 2024)

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas

Article in Journal of Neuro-Oncology (February 2024)

dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma

Article in Journal of Neuro-Oncology (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.